Charles Schwab Investment Management Inc Vaxxinity, Inc. Call Options Transaction History
Charles Schwab Investment Management Inc
- $429 Billion
- Q1 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding VAXX
# of Institutions
58Shares Held
12.2MCall Options Held
0Put Options Held
0-
Adage Capital Partners Gp, L.L.C. Boston, MA3MShares$810,0000.0% of portfolio
-
Black Rock Inc. New York, NY2.62MShares$708,2240.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.41MShares$651,1530.0% of portfolio
-
Geode Capital Management, LLC Boston, MA879KShares$237,2060.0% of portfolio
-
State Street Corp Boston, MA799KShares$215,8030.0% of portfolio
About Vaxxinity, Inc.
- Ticker VAXX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 112,150,000
- Market Cap $30.3M
- Description
- Vaxxinity, Inc., a biotechnology company, focuses on developing product candidates for human use in the fields of neurology and coronaviruses in the United States. The company engages in developing UB-311 that targets toxic forms of aggregated amyloid-b in the brain to fight Alzheimer's disease (AD) that is in phase 2 clinical trial; UB-312 that...